Baillie Gifford & Co’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,585
| Closed | -$10.8K | – | 326 |
|
|
2023
Q1 | $10.8K | Hold |
1,585
| – | – | ﹤0.01% | 394 |
|
|
2022
Q4 | $12.6K | Hold |
1,585
| – | – | ﹤0.01% | 395 |
|
|
2022
Q3 | $15K | Buy |
1,585
+154
| +11% | +$1.46K | ﹤0.01% | 365 |
|
|
2022
Q2 | $10K | Hold |
1,431
| – | – | ﹤0.01% | 408 |
|
|
2022
Q1 | $18K | Hold |
1,431
| – | – | ﹤0.01% | 374 |
|
|
2021
Q4 | $23K | Sell |
1,431
-174
| -11% | -$2.8K | ﹤0.01% | 359 |
|
|
2021
Q3 | $26K | Sell |
1,605
-202
| -11% | -$3.27K | ﹤0.01% | 332 |
|
|
2021
Q2 | $25K | Hold |
1,807
| – | – | ﹤0.01% | 336 |
|
|
2021
Q1 | $26K | Buy |
1,807
+104
| +6% | +$1.5K | ﹤0.01% | 313 |
|
|
2020
Q4 | $30K | Buy |
+1,703
| New | +$30K | ﹤0.01% | 292 |
|